GeoVax Labs Inc.
1256 Briarcliff Road
Atlanta
Georgia
30306
United States
Tel: 404-727-0971
Fax: 404-712-9357
Website: http://www.geovax.com/
275 articles about GeoVax Labs Inc.
-
GeoVax Labs Inc. Provides Clinical Studies Update
8/5/2009
-
GeoVax Labs Inc. Announces Resignation of Director
7/6/2009
-
GeoVax Labs Inc. Announces Results of 2009 Annual Shareholders Meeting
6/24/2009
-
Chuck Panozzo Joins GeoVax Labs Inc. as an Advocate for Its HIV/AIDS Vaccine
5/20/2009
-
GeoVax Labs Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
3/12/2009
-
GeoVax Labs Inc. Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA Trials in South America to Follow
2/20/2009
-
GeoVax Labs Inc. to Webcast Its Presentation at the Biotechnology Industry Organization (BIO) CEO & Investor 2009 Conference Webcast to be Held by Thomson Reuters
2/4/2009
-
GeoVax Labs Inc. and VGX International Announce Agreement at the Las Vegas “International Society of DNA Vaccines” Conference
12/8/2008
-
GeoVax Labs Inc.'s Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
12/1/2008
-
GeoVax Labs Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
11/10/2008
-
GeoVax Labs Inc.'s DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
10/20/2008
-
GeoVax Labs Inc. Appoints Mr. Peter M. Tsolinas to Its Board of Directors
8/22/2008
-
GeoVax Labs Inc. Announces Six Month Financial Results and Provides Operational Update
8/12/2008
-
GeoVax Labs Inc. Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology
7/22/2008
-
GeoVax Labs Inc. Reports Progress on Its AIDS Vaccine Technology
7/7/2008
-
GeoVax Labs Inc. Secures $10 Million Financing Commitment
5/13/2008
-
GeoVax Labs Inc. Announces New President and CEO
3/25/2008
-
GeoVax Labs Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
3/14/2008
-
GeoVax Labs Inc. Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
2/25/2008
-
GeoVax Labs Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference Planning for Phase 2 is Underway
2/7/2008